MIFAMURTIDE: 64 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
64
Total FAERS Reports
4 (6.3%)
Deaths Reported
36
Hospitalizations
64
As Primary/Secondary Suspect
12
Life-Threatening
18
Disabilities
First Report: 2013 · Latest Report: 20230815
What Are the Most Common MIFAMURTIDE Side Effects?
#1 Most Reported
Encephalopathy
13 reports (20.3%)
#2 Most Reported
Pyrexia
12 reports (18.8%)
#3 Most Reported
Confusional state
11 reports (17.2%)
All MIFAMURTIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Encephalopathy | 13 | 20.3% | 0 | 12 |
| Pyrexia | 12 | 18.8% | 1 | 9 |
| Confusional state | 11 | 17.2% | 0 | 9 |
| Leukoencephalopathy | 9 | 14.1% | 0 | 5 |
| Quadriplegia | 9 | 14.1% | 0 | 5 |
| Chills | 8 | 12.5% | 0 | 6 |
| Hemiparesis | 8 | 12.5% | 0 | 8 |
| Renal impairment | 8 | 12.5% | 0 | 8 |
| Allodynia | 7 | 10.9% | 0 | 0 |
| Aphasia | 7 | 10.9% | 0 | 5 |
| Drug clearance decreased | 7 | 10.9% | 0 | 7 |
| Drug level increased | 7 | 10.9% | 0 | 7 |
| Dysaesthesia | 7 | 10.9% | 0 | 0 |
| Headache | 6 | 9.4% | 0 | 6 |
| Malaise | 6 | 9.4% | 0 | 6 |
| Neuralgia | 6 | 9.4% | 0 | 0 |
| Nystagmus | 6 | 9.4% | 0 | 0 |
| Acute myeloid leukaemia | 5 | 7.8% | 0 | 5 |
| Affect lability | 5 | 7.8% | 0 | 5 |
| Agitation | 5 | 7.8% | 0 | 5 |
Who Reports MIFAMURTIDE Side Effects? Age & Gender Data
Gender: 46.8% female, 53.2% male. Average age: 17.8 years. Most reports from: GB. View detailed demographics →
Is MIFAMURTIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 3 | 1 | 0 |
| 2014 | 13 | 0 | 13 |
| 2015 | 7 | 0 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 9 | 0 | 5 |
| 2022 | 6 | 0 | 6 |
| 2023 | 1 | 0 | 0 |
What Is MIFAMURTIDE Used For?
| Indication | Reports |
|---|---|
| Osteosarcoma | 55 |
| Product used for unknown indication | 6 |
Official FDA Label for MIFAMURTIDE
Official prescribing information from the FDA-approved drug label.